Use of pentoxifylline in preparation of medicaments for preventing or treating constipation a pharmaceutical composition comprising pentoxifylline for preventing or treating constipation and a method for treating constipation by using pentoxifylline are disclosed. The trial of the present invention proves that pentoxifylline can improve constipation especially functional constipation.

Provided is a pharmaceutical composition for the treatment and prevention of alcoholic liver diseases including cilostazol as an active ingredient. Cilostazol inhibits expression levels of TNF-alpha and FAS (fatty acid synthase) gene in a concentration-dependent manner and also significantly inhibits the activity of caspase-3. Accordingly cilostazol shows superior effects for the treatment or prevention of alcoholic liver diseases in particular alcoholic hepatitis compared to pentoxifylline whic...

An animal model has been developed based the understanding that a central mechanism in patients with CTRF is that chemotherapy and/or radiation initiates canonical pathways leading to the development of disrupted sleep architecture, resulting in disruption of REM sleep and fatigue and cognitive dysfunction. Drugs that restore the activity patterns and levels towards normal and/or decrease the pro-inflammatory cytokines associated with the disrupted sleep, should be effective in alleviating one o...

FIELD: medicine.SUBSTANCE: invention refers to medicine, namely surgery, and may be used for treating patients with trophic ulcers. That is ensured by the sequential intravenous drop-by-drop introduction of a mixture containing 5% glucose 200 ml, 0.5% Novocaine 50 ml, 25% magnesium sulphate 5 ml

Use of pentoxifylline in preparation of medicaments for preventing or treating constipation, a pharmaceutical composition comprising pentoxifylline for preventing or treating constipation and a method for treating constipation by using pentoxifylline are disclosed. The trial of the present invention proves that pentoxifylline can improve constipation, especially functional constipation.

This invention relates to novel compounds that are substituted xanthine derivatives and pharmaceutically acceptable salts thereof. For example, this invention relates to novel substituted xanthine derivatives that are derivatives of pentoxifylline. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions for which pentoxifylline and related comp...